Kesimpta Pen Subcutaneous is a medication that is used to treat relapsing forms of multiple sclerosis (MS) in adults. It belongs to a class of drugs known as sphingosine 1-phosphate receptor modulators. This article provides an overview of the uses, benefits, side effects, and warnings associated with Kesimpta Pen Subcutaneous.
Uses
Kesimpta Pen Subcutaneous is primarily used for the treatment of relapsing forms of multiple sclerosis (MS) in adults. MS is a chronic autoimmune disease that affects the central nervous system, leading to symptoms such as muscle weakness, fatigue, and problems with coordination and balance. Kesimpta Pen Subcutaneous helps to reduce the number of relapses and delay the progression of disability in individuals with MS.
Benefits
There are several benefits associated with the use of Kesimpta Pen Subcutaneous:
- Reduced relapses: This medication helps to decrease the frequency of relapses, resulting in fewer episodes of MS symptoms.
- Delayed disability progression: Kesimpta Pen Subcutaneous can slow down the progression of disability in individuals with MS, allowing them to maintain a better quality of life.
- Convenient administration: The medication is administered subcutaneously using a pen, making it easy and convenient for patients to self-administer the medication at home.
- Long-lasting effects: Kesimpta Pen Subcutaneous is taken once a month, providing continuous protection against MS relapses.
Side Effects
While Kesimpta Pen Subcutaneous is generally well-tolerated, there are some potential side effects that individuals may experience:
- Infections: This medication may increase the risk of infections, including upper respiratory tract infections and urinary tract infections.
- Injection site reactions: Some individuals may experience redness, swelling, or pain at the injection site.
- Allergic reactions: Rarely, Kesimpta Pen Subcutaneous may cause allergic reactions, such as rash, itching, or difficulty breathing.
- Increased liver enzymes: Blood tests may show elevated liver enzymes in some individuals taking this medication.
- Increased blood pressure: Kesimpta Pen Subcutaneous may cause a temporary increase in blood pressure.
Warnings
Before starting treatment with Kesimpta Pen Subcutaneous, it is important to be aware of the following warnings:
- Infections: Individuals with a current infection or a history of chronic infections should exercise caution when using this medication.
- Immunizations: Live vaccines should be avoided while on Kesimpta Pen Subcutaneous, as they may not be as effective.
- Progressive multifocal leukoencephalopathy (PML): Rare cases of PML, a serious brain infection, have been reported in individuals taking Kesimpta Pen Subcutaneous. Symptoms may include changes in vision, difficulty speaking or walking, and cognitive changes.
- Macular edema: Kesimpta Pen Subcutaneous may cause macular edema, leading to changes in vision. Regular eye exams are recommended.
- Hepatitis B virus (HBV) reactivation: Individuals with a history of HBV infection should be closely monitored for signs of reactivation while on this medication.
FAQs
Here are some frequently asked questions about Kesimpta Pen Subcutaneous:
It may take a few weeks to several months for Kesimpta Pen Subcutaneous to start working. Consult your healthcare provider for more specific information based on your individual circumstances.
Yes, Kesimpta Pen Subcutaneous is designed for self-administration at home. Your healthcare provider will provide instructions on how to use the pen correctly.
No, Kesimpta Pen Subcutaneous is only approved for use in adults with relapsing forms of multiple sclerosis.
The safety of Kesimpta Pen Subcutaneous during pregnancy has not been established. Consult your healthcare provider if you are pregnant or planning to become pregnant.
It is generally recommended to avoid alcohol while taking any medication. However, consult your healthcare provider for personalized advice based on your specific situation.
 in adults.){kind=link}